Disrupted in Renal Carcinoma 2 (DIRC2) (Middle Region) Peptide
DIRC2
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN975800
Quick Overview for Disrupted in Renal Carcinoma 2 (DIRC2) (Middle Region) Peptide (ABIN975800)
Target
DIRC2
(Disrupted in Renal Carcinoma 2 (DIRC2))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-DIRC2 antibody (Catalog #: ARP50133_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- DIRC2 (Disrupted in Renal Carcinoma 2 (DIRC2))
-
Background
-
DIRC2 is a membrane-bound protein from the major facilitator superfamily of transporters. Disruption of DIRC2 by translocation has been associated with haplo-insufficiency and renal cell carcinomas. Alternatively spliced transcript variants have been described, but their biological validity has not yet been determined.This gene encodes a membrane-bound protein from the major facilitator superfamily of transporters. Disruption of this gene by translocation has been associated with haplo-insufficiency and renal cell carcinomas. Alternatively spliced transcript variants have been described, but their biological validity has not yet been determined. Sequence Note: The RefSeq transcript and protein were derived from genomic sequence and transcripts to make the sequence consistent with the reference genome assembly. The genomic coordinates used for the transcript record were based on alignments.
Alias Symbols: FLJ14784, RCC4
Protein Size: 478 -
Molecular Weight
- 52 kDa
-
Gene ID
- 84925
-
NCBI Accession
- NM_032839, NP_116228
-
UniProt
- Q96SL1
Target
-
You are here:
